| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 657.176 | 540.067 | 434.510 | 256.605 | 16.790 | 13.867 | 15.682 | 18.200 | - | - |
| Total Income - EUR | 669.469 | 542.627 | 436.524 | 758.630 | 19.396 | 15.101 | 17.004 | 19.685 | - | - |
| Total Expenses - EUR | 631.720 | 489.802 | 402.510 | 403.865 | 46.692 | 39.102 | 56.404 | 12.256 | - | - |
| Gross Profit/Loss - EUR | 37.748 | 52.825 | 34.013 | 354.764 | -27.297 | -24.000 | -39.400 | 7.429 | - | - |
| Net Profit/Loss - EUR | 31.671 | 43.579 | 19.109 | 348.234 | -27.491 | -24.151 | -39.807 | 6.839 | - | - |
| Employees | 3 | 3 | 3 | 3 | 1 | 1 | 1 | 0 | - | - |
Check the financial reports for the company - Perla Medifarm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 145.178 | 137.350 | 415.978 | 389.889 | 358.373 | 328.575 | 307.603 | 300.468 | - | - |
| Current Assets | 418.831 | 115.496 | 109.069 | 272.219 | 204.803 | 185.148 | 160.178 | 138.688 | - | - |
| Inventories | 79.094 | 48.838 | 52.200 | 1.164 | 1.141 | 1.152 | 1.135 | 1.141 | - | - |
| Receivables | 67.838 | 21.859 | 56.576 | 68.070 | 57.405 | 65.862 | 57.429 | 58.609 | - | - |
| Cash | 271.899 | 44.799 | 293 | 202.986 | 146.257 | 118.134 | 101.614 | 78.938 | - | - |
| Shareholders Funds | 288.593 | 44.726 | 19.632 | 366.674 | 332.083 | 301.636 | 255.137 | 262.768 | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | - | - |
| Debts | 275.851 | 208.293 | 505.415 | 364.232 | 298.559 | 278.274 | 240.429 | 201.510 | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Perla Medifarm Srl